(Q47869311)

English

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy

scientific article published on 19 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

prostate cancer

1 reference

based on heuristic

inferred from title

1

object named as

Caroline M Moore

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

Arnauld Villers

object named as

Arnauld Villers

4

0 references

13

object named as

Mark Emberton

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

author name string

Abel-Rahmene Azzouzi

2

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Eric Barret

3

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Gordon H Muir

5

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Neil J Barber

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Simon Bott

7

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

John Trachtenberg

8

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Nimalan Arumainayagam

9

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Bertrand Gaillac

10

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Clare Allen

11

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Avigdor Schertz

12

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

publication date

19 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

BJU International

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

116

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

6

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

888-896

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Time trends and local variation in primary treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Contemporary trends in low risk prostate cancer: risk assessment and treatment

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Quality of life outcomes following treatment for localized prostate cancer: is there a clear winner?

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

How good is MRI at detecting and characterising cancer within the prostate?

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

The role of focal therapy in the management of localised prostate cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Prompt assessment of WST11-VTP outcome using luciferase transfected tumors enables second treatment and increase in overall therapeutic rate.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Photocatalytic generation of oxygen radicals by the water-soluble bacteriochlorophyll derivative WST11, noncovalently bound to serum albumin.

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Pathological upgrading and up staging with immediate repeat biopsy in patients eligible for active surveillance

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Magnetic resonance imaging correlated with the histopathological effect of Pd-bacteriopheophorbide (Tookad) photodynamic therapy on the normal canine prostate gland

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Active surveillance for prostate cancer: a review

1 reference

https://api.crossref.org/works/10.1111%2FBJU.12816

21 January 2018

Identifiers

10.1111/BJU.12816

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 February 2018

http://europepmc.org/abstract/MED/24841929

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47869311&oldid=2173607548"